ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182CAA1. A total of 21 filers reported holding ANI PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $454,000 | +34.7% | 422,000 | +11.6% | 0.09% | +29.9% |
| Q1 2016 | $337,000 | -14.9% | 378,000 | -7.1% | 0.07% | -13.0% |
| Q4 2015 | $396,000 | +32.0% | 407,000 | +24.8% | 0.08% | +28.3% |
| Q3 2015 | $300,000 | -12.8% | 326,000 | +7.6% | 0.06% | -4.8% |
| Q2 2015 | $344,000 | – | 303,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 9,000,000 | $10,149,000 | 12.63% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 29,751,000 | $33,847,000 | 2.02% |
| Wellesley Asset Management | 25,925 | $29,366,000 | 1.76% |
| MANGROVE PARTNERS IM, LLC | 18,779 | $21,455,000 | 1.38% |
| Perceptive Advisors | 7,500,000 | $8,458,000 | 0.22% |
| OAKTREE CAPITAL MANAGEMENT LP | 6,857,000 | $7,767,000 | 0.11% |
| WOLVERINE ASSET MANAGEMENT LLC | 5,975,000 | $6,769,000 | 0.09% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,718,000 | $1,945,000 | 0.06% |
| CAMDEN ASSET MANAGEMENT L P /CA | 930,000 | $1,049,000 | 0.03% |
| GABELLI FUNDS LLC | 1,750,000 | $1,983,000 | 0.01% |